Persistent chemotherapy-induced peripheral neuropathy: Are dose reductions and drug modifications our only options?
Gynecol Oncol
.
2018 Jun;149(3):433-434.
doi: 10.1016/j.ygyno.2018.05.003.
Authors
Heidi S Donovan
1
,
Grace B Campbell
2
Affiliations
1
School of Nursing, University of Pittsburgh; Department of Obstetrics, Gynecology, and Reproductive Sciences, School of Medicine, University of Pittsburgh. Electronic address: donovanh@pitt.edu.
2
School of Nursing, University of Pittsburgh.
PMID:
29861308
DOI:
10.1016/j.ygyno.2018.05.003
No abstract available
Publication types
Editorial
Comment
MeSH terms
Antineoplastic Agents*
Humans
Longitudinal Studies
Ovarian Neoplasms*
Peripheral Nervous System Diseases*
Quality of Life
Substances
Antineoplastic Agents